AU Stock MarketDetailed Quotes

IMU Imugene Ltd

Watchlist
  • 0.036
  • 0.0000.00%
20min DelayTrading Dec 27 12:10 AET
272.41MMarket Cap-1.71P/E (Static)

Imugene Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Imugene Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 0.000--
--2025/H1-- / 0.000--
--2024/H20.000 / 0.000--
--2024/H10.000 / 0.000--
--2023/H20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 0.000--
--2025/H1-- / 0.000--
--2024/H20.000 / 0.000--
--2024/H10.000 / 0.000--
--2023/H20.000 / 0.000--

Unlock Free Earnings Estimates

Imugene Ltd Earnings Reports

  • Imugene Ltd: Appendix 4E and Annual Report

    Aug 30 04:43 ET

  • Imugene Ltd: Half Yearly Report and Accounts

    Feb 28 16:27 ET

  • Imugene Ltd: Amended Annual Report

    Oct 31, 2023 03:19 ET

  • Imugene Ltd: Preliminary Final Report - Reporting Adjustments

    Sep 29, 2023 02:20 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Rio Tinto Ltd
    RIO
    +1.12%
    Fortescue Ltd
    FMG
    +0.95%
    Woodside Energy Group Ltd
    WDS
    +0.66%
    Westpac Banking Corp
    WBC
    +0.69%
    National Australia Bank Ltd
    NAB
    +0.64%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Oct 23, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday+0.66%